Resolving ABO Discrepancies in Blood Typing
Uploaded by
Ali MalikResolving ABO Discrepancies in Blood Typing
Uploaded by
Ali MalikCommon questions
Powered by AIABO discrepancies can arise from several causes, including acquired B phenotype, subgroups of A, unexpected antibodies, rouleaux formation, immunocompromised status, and recent transfusions. For acquired B phenotype, history of infection or gastrointestinal malignancy should be checked and acidified serum should be used to differentiate from actual B antigens . Subgroups like A2 or A2B require anti-A1 lectin testing and adsorption-elution . Unexpected antibodies, such as cold autoantibodies or alloantibodies, necessitate warming samples and performing antibody identification . Rouleaux formation demands saline washing to distinguish it from agglutination . Immunocompromised patients or those who recently received transfusions need thorough history review or molecular typing to resolve discrepancies .
Alloantibodies are antibodies against non-ABO antigens that can react at room temperature with reagent red cells during reverse typing, causing weak or unexpected reactions. To resolve such discrepancies, ruling out autoantibodies is essential, followed by performing thorough antibody screening and adsorption-elution techniques to precisely identify and resolve the reactions causing the ABO typing issues .
Technical errors, such as incorrect sample handling or inefficient mixing of reagents, can lead to ABO discrepancies by causing false negative or positive readings. When suspecting technical issues, the first step should involve retesting the sample with fresh reagents and ensuring proper procedural execution, including accurate labeling and correct environmental conditions, to verify initial findings and eliminate errors in the blood typing results .
Mixed-field reactions in A3 subgroup patients occur due to the expression of weak A antigens, leading to partial agglutination observed as mf(2+/0), which appears weaker than reactions from recent transfusion situations . Recent transfusions provoke stronger mixed-field agglutination owing to the coexistence of patient and donor RBC populations, typically showing mf(4+/0). Differentiating requires careful evaluation of reaction patterns and historical transfusion records .
Resolving ABO discrepancies is vital for patient safety to prevent serious transfusion reactions or organ transplant mismatches that could prove life-threatening. These discrepancies are identified by observing mismatches between forward and reverse ABO grouping tests, such as unexpected weak or strong reactions . Critical steps involve interpreting reactions, identifying unlikely results, determining causes such as technical errors, alloantibodies, or recent transfusions, and implementing appropriate resolution strategies tailored to each scenario . Identification requires laboratory professionals to exercise diligence and critical evaluation to ensure safe transfusion services .
In immunocompromised individuals, such as the elderly or newborns, decreased antibody production can cause ABO discrepancies due to reduced isoagglutinins. Newborns often lack these antibodies due to an immature immune system, while elderly have naturally declining immune function . Managing these discrepancies involves understanding the patient's clinical condition and ensuring accurate history; molecular typing may be employed for precise blood grouping .
Anti-A1 lectin is used to differentiate between A1 and A2 subgroups when resolving ABO discrepancies. In cases where a subgroup of A is suspected (usually A2 or A2B), the forward grouping may react strongly with anti-A, while anti-A1 antibodies in reverse grouping react with A cells. Therefore, anti-A1 lectin is applied to confirm the presence or absence of A1 antigen, with no reaction indicating a subgroup classification .
Gram-negative bacterial infections can cause an acquired B phenotype by deacetylating N-acetylgalactosamine on group A red cells, making them resemble B antigens. Despite normal reverse typing, these cells weakly react with anti-B in forward typing . Resolution involves checking patient history for infections or gastrointestinal malignancy and using acidified serum, which does not react with the altered antigen to confirm true B presence .
Rouleaux formation interferes with ABO blood grouping by mimicking agglutination due to stacked coin-like appearance of red blood cells, particularly in conditions like multiple myeloma or Waldenström’s macroglobulinemia. To identify rouleaux formation, a microscopic examination should reveal this stacking. Correction involves using saline replacement for reverse reactions and saline washing for forward reactions to remove excess proteins and resolve the apparent agglutination .
Recent blood transfusions can lead to mixed-field agglutination due to the presence of both patient and donor RBC populations, particularly when group O cells are transfused. This causes partial reactions with anti-A and anti-B reagents. To resolve, microscopic examination for mixed-field agglutination is necessary, and the patient's transfusion history should be reviewed . Additional steps include performing antigen typing with cell separation or waiting for the clearance of transfused cells .